apoB fasting state
Selected indexed studies
- New targets for treating hypertriglyceridemia. (Curr Opin Endocrinol Diabetes Obes, 2022) [PMID:35045528]
- Food Intake Suppresses ApoB Secretion and Fractional Catabolic Rates in Humans. (Arterioscler Thromb Vasc Biol, 2024) [PMID:38126174]
- Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. (J Lipid Res, 1990) [PMID:1701004]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker. (2021) pubmed
- Non-fasting lipids detection and their significance in pregnant women. (2019) pubmed
- New targets for treating hypertriglyceridemia. (2022) pubmed
- Food Intake Suppresses ApoB Secretion and Fractional Catabolic Rates in Humans. (2024) pubmed
- Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. (1990) pubmed
- Helicobacter pylori infection and apolipoprotein B/apolipoprotein A1 ratio: a cross-sectional study. (2025) pubmed
- Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes. (2020) pubmed
- Atherogenic ApoB-dyslipidemia, atherosclerotic cardiovascular disease, cardiac dysfunction and remodeling in high-risk young women with and without polycystic ovary syndrome: A pilot study. (2025) pubmed
- Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. (2003) pubmed
- The association of apolipoprotein B with chronic kidney disease in the Chinese population. (2023) pubmed